Activation of the transcription factor NF-kappaB in lipopolysaccharide-stimulated U937 cells

Biochem Pharmacol. 1997 Feb 7;53(3):339-46. doi: 10.1016/s0006-2952(96)00715-0.

Abstract

During the course of serious bacterial infections, lipopolysaccharide (LPS) interacts with monocyte/macrophage receptors, resulting in the generation of inflammatory cytokines. Transcription factor NF-kappaB is crucial in activating the transcription of genes encoding proinflammatory cytokines. In this paper, we demonstrate that the activation of NF-kappaB by LPS in a promonocytic cell line (U937) followed a rather slow kinetics, depending on the rate of IkappaB-alpha inhibitor hydrolysis. No degradation of p105 and p100 inhibitors was observed under these conditions. The transduction pathway leading to NF-kappaB activation in U937 cells involved the intracellular generation of reactive oxygen species (ROS), as demonstrated by the concomitant inhibitory effects of antioxidants on NF-kappaB activation and the emission of a fluorescent probe reacting intracellularly with hydrogen peroxide. This ROS pathway was also characterized by the use of other inhibitors. This finding indicates that phospholipase A2 and 5-lipoxygenase are also involved. However, the NF-kappaB activation pathway involving the acidic sphingomyelinase of the endolysosomial membrane did not seem to participate in the LPS-induced NF-kappaB activation in U937 cells.

MeSH terms

  • Antioxidants / pharmacology
  • Biological Transport / drug effects
  • Cell Line
  • Humans
  • Hydrogen Peroxide / metabolism
  • Interleukin-1 / pharmacology
  • Lipopolysaccharides / pharmacology*
  • Lipoxygenase / physiology
  • Monocytes / metabolism
  • NF-kappa B / metabolism*
  • Phospholipases A / physiology
  • Phospholipases A2
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antioxidants
  • Interleukin-1
  • Lipopolysaccharides
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Hydrogen Peroxide
  • Lipoxygenase
  • Phospholipases A
  • Phospholipases A2